The LaserBlood team participated in the 3rd National Congress of AICEP, held in Padova, Italy, from April 3 to 5, 2024. This event brought together experts to discuss advancements in hepatobiliary and pancreatic (HPB) surgery, clinical and therapeutic progress—including targeted therapies and immunotherapy—minimally invasive surgical techniques, innovations in liver transplantation, and the latest updates in tumor ablation treatments.
The congress provided a valuable platform for scientific, clinical, and technological exchange, aligning with LaserBlood’s commitment to innovation in pancreatic cancer research and diagnostics.